サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1751259

内視鏡用止血デバイスの市場規模、シェア、動向分析レポート：製品別、最終用途別、地域別、セグメント予測、2025年～2030年

Endoscopic Hemostasis Devices Market Size, Share & Trends Analysis Report By Product (Ligation Clips, Ligation Bands, Injection Needles, Hemostatic Spray), By End Use, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.72円
内視鏡用止血デバイスの市場規模、シェア、動向分析レポート：製品別、最終用途別、地域別、セグメント予測、2025年～2030年
出版日: 2025年05月22日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

市場規模と動向：

内視鏡用止血デバイスの世界市場規模は2024年に21億米ドルと推計され、2025年から2030年にかけてCAGR 3.79％で拡大すると予測されています。

胃静脈瘤、消化性潰瘍、消化管がんなど消化管疾患の有病率の増加が、内視鏡的止血デバイスの需要増につながっています。

例えば、消化性潰瘍の増加により、内視鏡手術中の効果的な出血管理が必要となり、これが市場成長に寄与しています。このような疾患の有病率が増加するにつれて、一般外科手術における高度な止血デバイスの必要性が高まり、市場のさらなる成長が促進されます。

世界のヘルスケアシステムでは、生存率を向上させるために、がんの早期発見・早期治療のためのがん管理プロトコールに内視鏡的手技を取り入れる傾向が強まっています。この動向と世界のがん負担の増加が内視鏡需要を押し上げ、市場成長をさらに促進すると予想されます。さらに、市場のメーカーは、効果的ながん治療のための最先端技術を装備することを目指し、増大する臨床ニーズに対応するため、継続的に技術革新を行い、製品ラインを拡大しています。

啓発キャンペーンやがん検診プログラムなど、政府の積極的な取り組みが内視鏡用止血デバイスの需要を促進すると期待されています。例えば、CDCは、2021年7月から2022年6月にかけて、大腸がん対策プログラム（CRCCP）の提携クリニックが約19万8,000人の大腸がん検診を実施し、前年比35%増（5万1,084件の追加検診）を記録したと報告しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 内視鏡用止血デバイス市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 補助市場の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 内視鏡用止血デバイス：市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTLE分析
  • テクノロジー情勢
  • ケーススタディ分析

第4章 内視鏡用止血デバイス市場セグメント分析、製品別、2018年～2030年

  • 定義と範囲
  • 製品別市場シェア分析、2024年および2030年
  • セグメントダッシュボード
  • 内視鏡用止血デバイスの世界市場（製品別、2018～2030年）
  • 結紮クリップ
  • 結紮バンド
  • 痔
  • 食道
  • 注射針
  • 止血スプレー
  • サーマルプローブ
  • 接触プローブ
  • 非接触プローブ
  • アルゴンプラズマ凝固法（APC）
  • 高周波アブレーション（RFA）

第5章 内視鏡用止血デバイス市場セグメント分析、最終用途別、2018年～2030年

  • 定義と範囲
  • 最終用途別市場シェア分析、2024年および2030年
  • セグメントダッシュボード
  • 世界の内視鏡用止血デバイス市場（最終用途別、2018～2030年）
  • 病院
  • 外来施設

第6章 内視鏡用止血デバイス市場セグメント分析、地域別、2018年～2030年

  • 地域別市場シェア分析、2024年および2030年
  • 地域別市場ダッシュボード
  • 地域別市場のスナップショット
  • 内視鏡用止血デバイスの市場シェア：地域別、2024年および2030年
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業分類
  • 企業プロファイル
    • Boston Scientific Corporation
    • CONMED Corporation
    • Olympus Corporation
    • STERIS
    • Medtronic
    • MICRO-TECH（Nanjing）Co., Ltd.
    • B. Braun SE
    • Diversatek, Inc.
    • Cook
    • Duomed
図表

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global Endoscopic Hemostasis Products Market, By Product, 2018 - 2030 (USD Million)
  • Table 4. Global Endoscopic Hemostasis Products Market, By End Use, 2018 - 2030 (USD Million)
  • Table 5. Global Endoscopic Hemostasis Products Market, By Region, 2018 - 2030 (USD Million)
  • Table 6. North America Endoscopic Hemostasis Products Market, By Product, 2018 - 2030 (USD Million)
  • Table 7. North America Endoscopic Hemostasis Products Market, By End Use, 2018 - 2030 (USD Million)
  • Table 8. U.S. Endoscopic Hemostasis Products Market, By Product, 2018 - 2030 (USD Million)
  • Table 9. U.S. Endoscopic Hemostasis Products Market, By End Use, 2018 - 2030 (USD Million)
  • Table 10. Canada Endoscopic Hemostasis Products Market, By Product, 2018 - 2030 (USD Million)
  • Table 11. Canada Endoscopic Hemostasis Products Market, By End Use, 2018 - 2030 (USD Million)
  • Table 12. Mexico Endoscopic Hemostasis Products Market, By Product, 2018 - 2030 (USD Million)
  • Table 13. Mexico Endoscopic Hemostasis Products Market, By End Use, 2018 - 2030 (USD Million)
  • Table 14. Europe Endoscopic Hemostasis Products Market, by Country, 2018 - 2030 (USD Million)
  • Table 15. Europe Endoscopic Hemostasis Products Market, By Product, 2018 - 2030 (USD Million)
  • Table 16. Europe Endoscopic Hemostasis Products Market, By End Use, 2018 - 2030 (USD Million)
  • Table 17. UK Endoscopic Hemostasis Products Market, By Product, 2018 - 2030 (USD Million)
  • Table 18. UK Endoscopic Hemostasis Products Market, By End Use, 2018 - 2030 (USD Million)
  • Table 19. Germany Endoscopic Hemostasis Products Market, By Product, 2018 - 2030 (USD Million)
  • Table 20. Germany Endoscopic Hemostasis Products Market, By End Use, 2018 - 2030 (USD Million)
  • Table 21. France Endoscopic Hemostasis Products Market, By Product, 2018 - 2030 (USD Million)
  • Table 22. France Endoscopic Hemostasis Products Market, By End Use, 2018 - 2030 (USD Million)
  • Table 23. Italy Endoscopic Hemostasis Products Market, By Product, 2018 - 2030 (USD Million)
  • Table 24. Italy Endoscopic Hemostasis Products Market, By End Use, 2018 - 2030 (USD Million)
  • Table 25. Spain Endoscopic Hemostasis Products Market, By Product, 2018 - 2030 (USD Million)
  • Table 26. Spain Endoscopic Hemostasis Products Market, By End Use, 2018 - 2030 (USD Million)
  • Table 27. Denmark Endoscopic Hemostasis Products Market, By Product, 2018 - 2030 (USD Million)
  • Table 28. Denmark Endoscopic Hemostasis Products Market, By End Use, 2018 - 2030 (USD Million)
  • Table 29. Sweden Endoscopic Hemostasis Products Market, By Product, 2018 - 2030 (USD Million)
  • Table 30. Sweden Endoscopic Hemostasis Products Market, By End Use, 2018 - 2030 (USD Million)
  • Table 31. Norway Endoscopic Hemostasis Products Market, By Product, 2018 - 2030 (USD Million)
  • Table 32. Norway Endoscopic Hemostasis Products Market, By End Use, 2018 - 2030 (USD Million)
  • Table 33. Asia Pacific Endoscopic Hemostasis Products Market, by Country, 2018 - 2030 (USD Million)
  • Table 34. Asia Pacific Endoscopic Hemostasis Products Market, By Product, 2018 - 2030 (USD Million)
  • Table 35. Asia Pacific Endoscopic Hemostasis Products Market, By End Use, 2018 - 2030 (USD Million)
  • Table 36. Japan Endoscopic Hemostasis Products Market, By Product, 2018 - 2030 (USD Million)
  • Table 37. Japan Endoscopic Hemostasis Products Market, By End Use, 2018 - 2030 (USD Million)
  • Table 38. China Endoscopic Hemostasis Products Market, By Product, 2018 - 2030 (USD Million)
  • Table 39. China Endoscopic Hemostasis Products Market, By End Use, 2018 - 2030 (USD Million)
  • Table 40. India Endoscopic Hemostasis Products Market, By Product, 2018 - 2030 (USD Million)
  • Table 41. India Endoscopic Hemostasis Products Market, By End Use, 2018 - 2030 (USD Million)
  • Table 42. Australia Endoscopic Hemostasis Products Market, By Product, 2018 - 2030 (USD Million)
  • Table 43. Australia Endoscopic Hemostasis Products Market, By End Use, 2018 - 2030 (USD Million)
  • Table 44. Thailand Endoscopic Hemostasis Products Market, By Product, 2018 - 2030 (USD Million)
  • Table 45. Thailand Endoscopic Hemostasis Products Market, By End Use, 2018 - 2030 (USD Million)
  • Table 46. South Korea Endoscopic Hemostasis Products Market, By Product, 2018 - 2030 (USD Million)
  • Table 47. South Korea Endoscopic Hemostasis Products Market, By End Use, 2018 - 2030 (USD Million)
  • Table 48. Latin America Endoscopic Hemostasis Products Market, by Country, 2018 - 2030 (USD Million)
  • Table 49. Latin America Endoscopic Hemostasis Products Market, By Product, 2018 - 2030 (USD Million)
  • Table 50. Latin America Endoscopic Hemostasis Products Market, By End Use, 2018 - 2030 (USD Million)
  • Table 51. Brazil Endoscopic Hemostasis Products Market, By Product, 2018 - 2030 (USD Million)
  • Table 52. Brazil Endoscopic Hemostasis Products Market, By End Use, 2018 - 2030 (USD Million)
  • Table 53. Argentina Endoscopic Hemostasis Products Market, By Product, 2018 - 2030 (USD Million)
  • Table 54. Argentina Endoscopic Hemostasis Products Market, By End Use, 2018 - 2030 (USD Million)
  • Table 55. Middle East & Africa Endoscopic Hemostasis Products Market, by Country, 2018 - 2030 (USD Million)
  • Table 56. Middle East & Africa Endoscopic Hemostasis Products Market, By Product, 2018 - 2030 (USD Million)
  • Table 57. Middle East & Africa Endoscopic Hemostasis Products Market, By End Use, 2018 - 2030 (USD Million)
  • Table 58. South Africa Endoscopic Hemostasis Products Market, By Product, 2018 - 2030 (USD Million)
  • Table 59. South Africa Endoscopic Hemostasis Products Market, By End Use, 2018 - 2030 (USD Million)
  • Table 60. Saudi Arabia Endoscopic Hemostasis Products Market, By Product, 2018 - 2030 (USD Million)
  • Table 61. Saudi Arabia Endoscopic Hemostasis Products Market, By End Use, 2018 - 2030 (USD Million)
  • Table 62. UAE Endoscopic Hemostasis Products Market, By Product, 2018 - 2030 (USD Million)
  • Table 63. UAE Endoscopic Hemostasis Products Market, By End Use, 2018 - 2030 (USD Million)
  • Table 64. Kuwait Endoscopic Hemostasis Products Market, By Product, 2018 - 2030 (USD Million)
  • Table 65. Kuwait Endoscopic Hemostasis Products Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Endoscopic Hemostasis Devices market: outlook
  • Fig. 8 Endoscopic Hemostasis Devices competitive insights
  • Fig. 9 Ancillary market outlook
  • Fig. 10 Endoscopic Hemostasis Devices market driver impact
  • Fig. 11 Endoscopic Hemostasis Devices market restraint impact
  • Fig. 12 Porter's Analysis
  • Fig. 13 PESTLE Analysis
  • Fig. 14 Endoscopic Hemostasis Devices market: Product movement analysis
  • Fig. 15 Endoscopic Hemostasis Devices market: Product outlook and key takeaways
  • Fig. 16 Ligation Clips market estimates and forecast, 2018 - 2030
  • Fig. 17 Ligation Bands market estimates and forecast, 2018 - 2030
  • Fig. 18 Hemorrhoidal market estimates and forecast, 2018 - 2030
  • Fig. 19 Esophageal market estimates and forecast, 2018 - 2030
  • Fig. 20 Injection Needles market estimates and forecast, 2018 - 2030
  • Fig. 21 Hemostatic Spray market estimates and forecast, 2018 - 2030
  • Fig. 22 Thermal Probes market estimates and forecast, 2018 - 2030
  • Fig. 23 Contact Probes market estimates and forecast, 2018 - 2030
  • Fig. 24 Noncontact Probes market estimates and forecast, 2018 - 2030
  • Fig. 25 Argon Plasma Coagulation (APC) market estimates and forecast, 2018 - 2030
  • Fig. 26 Radiofrequency Ablation (RFA) market estimates and forecast, 2018 - 2030
  • Fig. 27 Endoscopic Hemostasis Devices market: End Use movement analysis
  • Fig. 28 Endoscopic Hemostasis Devices market: End Use outlook and key takeaways
  • Fig. 29 Hospitals market estimates and forecasts, 2018 - 2030
  • Fig. 30 Outpatient Facilities market estimates and forecasts,2018 - 2030
  • Fig. 31 Global endoscopic hemostasis devices market: Regional movement analysis
  • Fig. 32 Global endoscopic hemostasis devices market: Regional outlook and key takeaways
  • Fig. 33 North America endoscopic hemostasis devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Key country dynamics
  • Fig. 35 US endoscopic hemostasis devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Key country dynamics
  • Fig. 37 Canada endoscopic hemostasis devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Key country dynamics
  • Fig. 39 Mexico endoscopic hemostasis devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Europe endoscopic hemostasis devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Key country dynamics
  • Fig. 42 UK endoscopic hemostasis devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Key country dynamics
  • Fig. 44 Germany endoscopic hemostasis devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Key country dynamics
  • Fig. 46 Spain endoscopic hemostasis devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 France endoscopic hemostasis devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Italy endoscopic hemostasis devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Norway endoscopic hemostasis devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 Denmark endoscopic hemostasis devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Sweden endoscopic hemostasis devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Asia Pacific endoscopic hemostasis devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Japan endoscopic hemostasis devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 China endoscopic hemostasis devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 India endoscopic hemostasis devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Australia endoscopic hemostasis devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 South Korea endoscopic hemostasis devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Thailand endoscopic hemostasis devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Latin America endoscopic hemostasis devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Brazil endoscopic hemostasis devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 Argentina endoscopic hemostasis devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 MEA endoscopic hemostasis devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 South Africa endoscopic hemostasis devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Saudi Arabia endoscopic hemostasis devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 UAE endoscopic hemostasis devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 Kuwait endoscopic hemostasis devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Key company categorization
  • Fig. 85 Heat map analysis, 2024
目次
Product Code: GVR-4-68040-588-0

Market Size & Trends:

The global endoscopic hemostasis devices market size was estimated at USD 2.10 billion in 2024 and is expected to expand at a CAGR of 3.79% from 2025 to 2030. The growing prevalence of gastrointestinal disorders, including gastric varices, peptic ulcers, and gastrointestinal cancers, is leading to a higher demand for endoscopic hemostasis devices.

For instance, the rise in peptic ulcer cases necessitates effective bleeding management during endoscopic procedures, which is contributing to market growth. As the prevalence of these conditions increases, the requirement for advanced hemostasis devices in general surgery will grow, driving further market growth.

Healthcare systems worldwide are increasingly incorporating endoscopic procedures into their cancer management protocols for early detection and treatment of cancer to improve survival rates. This trend and the rising global cancer burden are expected to boost endoscope demand, further driving market growth. Moreover, manufacturers in the market continuously innovate and expand their product lines to meet the growing clinical needs, aiming to equip them with the most advanced technology for effective cancer treatment.

Favorable government initiatives, including awareness campaigns and cancer screening programs, are expected to drive the demand for endoscopic hemostasis devices. For instance, the CDC reported that from July 2021 to June 2022, partner clinics in the Colorectal Cancer Control Program (CRCCP) screened nearly 198,000 individuals for colorectal cancer, marking a 35% increase (51,084 additional screenings) compared to the previous year.

Global Endoscopic Hemostasis Devices Market Report Segmentation

This report forecasts revenue growth and provides at global, regional, and country levels an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this report, Grand View Research has segmented the global endoscopic hemostasis devices market report based on product, end use, and region:

  • Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Ligation Clips
  • Ligation Bands
    • Hemorrhoidal
    • Esophageal
  • Injection Needles
  • Hemostatic Spray
  • Thermal Probes
    • Contact Probes
    • Noncontact Probes
  • Argon Plasma Coagulation (APC)
  • Radiofrequency Ablation (RFA)
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Outpatient Facilities
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment scope
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.7. Research Assumptions
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. End Use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Endoscopic Hemostasis Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Endoscopic Hemostasis Devices: Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTLE Analysis
  • 3.4. Technology Landscape
  • 3.5. Case Study Analysis

Chapter 4. Endoscopic Hemostasis Devices Market Segment Analysis, By Product, 2018-2030 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Product Market Share Analysis, 2024 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Endoscopic Hemostasis Devices Market, by Product, 2018 to 2030
  • 4.5. Ligation Clips
    • 4.5.1. Ligation Clips Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Ligation Bands
    • 4.6.1. Ligation Bands Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.2. Hemorrhoidal
      • 4.6.2.1. Hemorrhoidal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.3. Esophageal
      • 4.6.3.1. Esophageal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Injection Needles
    • 4.7.1. Injection Needles Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Hemostatic Spray
    • 4.8.1. Hemostatic Spray Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.9. Thermal Probes
    • 4.9.1. Thermal Probes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.9.2. Contact Probes
      • 4.9.2.1. Contact Probes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.9.3. Noncontact Probes
      • 4.9.3.1. Noncontact Probes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.10. Argon Plasma Coagulation (APC)
    • 4.10.1. Argon Plasma Coagulation (APC) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.11. Radiofrequency Ablation (RFA)
    • 4.11.1. Radiofrequency Ablation (RFA) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Endoscopic Hemostasis Devices Market Segment Analysis, By End Use, 2018-2030 (USD Million)

  • 5.1. Definition and Scope
  • 5.2. End Use Market Share Analysis, 2024 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Global Endoscopic Hemostasis Devices Market, by End Use, 2018 to 2030
  • 5.5. Hospitals
    • 5.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Outpatient Facilities
    • 5.6.1. Outpatient Facilities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Endoscopic Hemostasis Devices Market Segment Analysis, By Region, 2018 - 2030 (USD Million)

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Regional Market Snapshot
  • 6.4. Endoscopic Hemostasis Devices Market Share by Region, 2024 & 2030:
  • 6.5. North America
    • 6.5.1. North America endoscopic hemostasis devices market, 2018 - 2030 (USD Million)
    • 6.5.2. U.S.
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Regulatory Scenario
      • 6.5.2.3. Competitive Scenario
      • 6.5.2.4. U.S. endoscopic hemostasis devices market, 2018 - 2030 (USD Million)
    • 6.5.3. Canada
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Regulatory Scenario
      • 6.5.3.3. Competitive Scenario
      • 6.5.3.4. Canada endoscopic hemostasis devices market, 2018 - 2030 (USD Million)
    • 6.5.4. Mexico
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Regulatory Scenario
      • 6.5.4.3. Competitive Scenario
      • 6.5.4.4. Mexico endoscopic hemostasis devices market, 2018 - 2030 (USD Million)
  • 6.6. Europe
    • 6.6.1. Europe endoscopic hemostasis devices market, 2018 - 2030 (USD Million)
    • 6.6.2. UK
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Regulatory Scenario
      • 6.6.2.3. Competitive Scenario
      • 6.6.2.4. UK endoscopic hemostasis devices market, 2018 - 2030 (USD Million)
    • 6.6.3. Germany
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Regulatory Scenario
      • 6.6.3.3. Competitive Scenario
      • 6.6.3.4. Germany endoscopic hemostasis devices market, 2018 - 2030 (USD Million)
    • 6.6.4. France
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Regulatory Scenario
      • 6.6.4.3. Competitive Scenario
      • 6.6.4.4. France endoscopic hemostasis devices market, 2018 - 2030 (USD Million)
    • 6.6.5. Italy
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Regulatory Scenario
      • 6.6.5.3. Competitive Scenario
      • 6.6.5.4. Italy endoscopic hemostasis devices market, 2018 - 2030 (USD Million)
    • 6.6.6. Spain
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Regulatory Scenario
      • 6.6.6.3. Competitive Scenario
      • 6.6.6.4. Spain endoscopic hemostasis devices market, 2018 - 2030 (USD Million)
    • 6.6.7. Norway
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Regulatory Scenario
      • 6.6.7.3. Competitive Scenario
      • 6.6.7.4. Norway endoscopic hemostasis devices market, 2018 - 2030 (USD Million)
    • 6.6.8. Sweden
      • 6.6.8.1. Key Country Dynamics
      • 6.6.8.2. Regulatory Scenario
      • 6.6.8.3. Competitive Scenario
      • 6.6.8.4. Sweden endoscopic hemostasis devices market, 2018 - 2030 (USD Million)
    • 6.6.9. Denmark
      • 6.6.9.1. Key Country Dynamics
      • 6.6.9.2. Regulatory Scenario
      • 6.6.9.3. Competitive Scenario
      • 6.6.9.4. Denmark endoscopic hemostasis devices market, 2018 - 2030 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key Country Dynamics
      • 6.7.1.2. Regulatory Scenario
      • 6.7.1.3. Competitive Scenario
      • 6.7.1.4. Japan endoscopic hemostasis devices market, 2018 - 2030 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Regulatory Scenario
      • 6.7.2.3. Competitive Scenario
      • 6.7.2.4. China endoscopic hemostasis devices market, 2018 - 2030 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Regulatory Scenario
      • 6.7.3.3. Competitive Scenario
      • 6.7.3.4. India endoscopic hemostasis devices market, 2018 - 2030 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Regulatory Scenario
      • 6.7.4.3. Competitive Scenario
      • 6.7.4.4. Australia endoscopic hemostasis devices market, 2018 - 2030 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key Country Dynamics
      • 6.7.5.2. Regulatory Scenario
      • 6.7.5.3. Competitive Scenario
      • 6.7.5.4. South Korea endoscopic hemostasis devices market, 2018 - 2030 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key Country Dynamics
      • 6.7.6.2. Regulatory Scenario
      • 6.7.6.3. Competitive Scenario
      • 6.7.6.4. Thailand endoscopic hemostasis devices market, 2018 - 2030 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key Country Dynamics
      • 6.8.1.2. Regulatory Scenario
      • 6.8.1.3. Competitive Scenario
      • 6.8.1.4. Brazil endoscopic hemostasis devices market, 2018 - 2030 (USD Million)
    • 6.8.2. Argentina
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Regulatory Scenario
      • 6.8.2.3. Competitive Scenario
      • 6.8.2.4. Argentina endoscopic hemostasis devices market, 2018 - 2030 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key Country Dynamics
      • 6.9.1.2. Regulatory Scenario
      • 6.9.1.3. Competitive Scenario
      • 6.9.1.4. South Africa endoscopic hemostasis devices market, 2018 - 2030 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key Country Dynamics
      • 6.9.2.2. Regulatory Scenario
      • 6.9.2.3. Competitive Scenario
      • 6.9.2.4. Saudi Arabia endoscopic hemostasis devices market, 2018 - 2030 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key Country Dynamics
      • 6.9.3.2. Regulatory Scenario
      • 6.9.3.3. Competitive Scenario
      • 6.9.3.4. UAE endoscopic hemostasis devices market, 2018 - 2030 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key Country Dynamics
      • 6.9.4.2. Regulatory Scenario
      • 6.9.4.3. Competitive Scenario
      • 6.9.4.4. Kuwait endoscopic hemostasis devices market, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Profiles
    • 7.3.1. Boston Scientific Corporation
      • 7.3.1.1. Company overview
      • 7.3.1.2. Financial performance
      • 7.3.1.3. Platform benchmarking
      • 7.3.1.4. Strategic initiatives
    • 7.3.2. CONMED Corporation
      • 7.3.2.1. Company overview
      • 7.3.2.2. Financial performance
      • 7.3.2.3. Platform benchmarking
      • 7.3.2.4. Strategic initiatives
    • 7.3.3. Olympus Corporation
      • 7.3.3.1. Company overview
      • 7.3.3.2. Financial performance
      • 7.3.3.3. Platform benchmarking
      • 7.3.3.4. Strategic initiatives
    • 7.3.4. STERIS
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Platform benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Medtronic
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Platform benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. MICRO-TECH (Nanjing) Co., Ltd.
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Platform benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. B. Braun SE
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Platform benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Diversatek, Inc.
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Platform benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Cook
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Platform benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Duomed
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Platform benchmarking
      • 7.3.10.4. Strategic initiatives